找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Differentiated Thyroid Cancer; Anne T. Mancino,Lawrence T. Kim Book 2017 The Editor(s) (if applicable) and The Author(s) 201

[復(fù)制鏈接]
樓主: Inspection
41#
發(fā)表于 2025-3-28 18:32:19 | 只看該作者
The Debate , Elective Lymph Node Dissection in Papillary Thyroid Carcinoma,roximately 40% of patients with tumours >1 cm will have central node compartment metastases that are clinically undetectable. The performance of a routine or prophylactic central node dissection ensures that clinically undetectable nodal metastases are resected. Information about nodal status can be
42#
發(fā)表于 2025-3-28 19:39:49 | 只看該作者
The Debate , Elective Lymph Node Dissection in Papillary Thyroid Carcinoma,s practice results in improved survival and reduced rates of recurrence and prevents complications from avoiding future salvage surgery and that it streamlines treatment by selecting those patients most likely to benefit from adjuvant therapy. We go on to consider the morbidity of the procedure in t
43#
發(fā)表于 2025-3-29 02:26:22 | 只看該作者
Differentiated Thyroid Cancer: Prognostic and Risk Assessment Systems, predicted outcome. The key prognostic variables include patient age, tumor size, presence of lymph node or distant metastases, invasive behavior of the tumor, and grade or histology of the tumor. In this chapter, each of these variables is discussed in depth. In addition all of the major staging sy
44#
發(fā)表于 2025-3-29 03:22:52 | 只看該作者
Role of Radioactive Iodine for Remnant Ablation in Patients with Papillary Thyroid Cancer,ree decades. In our chapter, we consider the implications of the recently published American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid carcinoma (DTC) and hope to clarify for our readers where we currently stand on their Recommendati
45#
發(fā)表于 2025-3-29 10:25:56 | 只看該作者
Considerations in Thyrotropin-Stimulating Hormone Suppression in Individuals with Differentiated Thal rate at 5 years of 97.9%. Most commonly, DTC is first treated primarily by surgical resection of either the total thyroid or partial thyroid. In patients who have undergone a total thyroidectomy, thyroxine replacement therapy will be required for the rest of their lives and may be required in tho
46#
發(fā)表于 2025-3-29 13:54:44 | 只看該作者
47#
發(fā)表于 2025-3-29 17:51:34 | 只看該作者
48#
發(fā)表于 2025-3-29 23:24:49 | 只看該作者
49#
發(fā)表于 2025-3-30 02:37:33 | 只看該作者
Lymph Node Dissection for Differentiated Thyroid Cancer, anatomy of the neck and the frequency of nodal involvement in differentiated thyroid cancer and reviews the indications for lymphadenectomy, including the controversial utility of prophylactic nodal dissections. The chapter provides extensive details regarding the technical aspects of both central and lateral compartment lymph node dissections.
50#
發(fā)表于 2025-3-30 05:10:38 | 只看該作者
Anne T. Mancino,Lawrence T. KimWritten by experts in the field.Provides a concise yet comprehensive summary of the field.Includes the most up-to-date scientific and clinical information
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 17:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
建水县| 成都市| 宜兰县| 新沂市| 保定市| 广平县| 尉氏县| 屯留县| 郧西县| 满城县| 永修县| 嘉义县| 德庆县| 凉山| 开江县| 尉犁县| 建宁县| 深水埗区| 曲松县| 容城县| 新宾| 东辽县| 拜泉县| 玉环县| 甘泉县| 万州区| 富宁县| 海林市| 遂平县| 尼木县| 陵水| 临泽县| 塔河县| 本溪| 米易县| 鲁甸县| 巴楚县| 边坝县| 会理县| 化州市| 安福县|